Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-Associated Lipodystrophy”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Post-approval studies (Phase 4)Study completedNCT00192660
What this trial is testing

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Who this might be right for
HIV-Associated Lipodystrophy SyndromeCardiovascular Disease
Kirby Institute 80
Post-approval studies (Phase 4)Ended earlyNCT00122655
What this trial is testing

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Who this might be right for
HIV InfectionsHIV Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 100
Not applicableStudy completedNCT01511016
What this trial is testing

Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Who this might be right for
HIV Lipodystrophy
Baylor College of Medicine 17
Post-approval studies (Phase 4)UnknownNCT00135460
What this trial is testing

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Danish HIV Research Group 100
Early research (Phase 1)Study completedNCT02009462
What this trial is testing

Artefill for the Treatment of HIV-associated Facial Lipoatrophy

Who this might be right for
HIV-facial Lipoatrophy
Gerald Pierone, Jr. M.D. 31
Post-approval studies (Phase 4)UnknownNCT00122226
What this trial is testing

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
Amsterdam UMC, location VUmc 50
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Testing effectiveness (Phase 2)Study completedNCT00130286
What this trial is testing

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Who this might be right for
HIV-Associated Lipodystrophy SyndromeInsulin ResistanceHIV Infections+2 more
Weill Medical College of Cornell University 77
Not applicableUnknownNCT00662181
What this trial is testing

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
Hvidovre University Hospital 46
Not applicableStudy completedNCT01405456
What this trial is testing

Eplerenone in HIV Associated Abdominal Fat Accumulation

Who this might be right for
HIV
Massachusetts General Hospital 46
Testing effectiveness (Phase 2)Study completedNCT02684591
What this trial is testing

Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy

Who this might be right for
Nonalcoholic Fatty Liver DiseaseHIV
University of California, San Diego 50
Not applicableStudy completedNCT00069004
What this trial is testing

Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy SyndromeHIV Lipodystrophy Syndrome+4 more
National Institute of Allergy and Infectious Diseases (NIAID) 450
Not applicableUnknownNCT04887675
What this trial is testing

Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI

Who this might be right for
HIV I InfectionHIV Associated LipodystrophyMetabolic Syndrome+1 more
University of Novi Sad 120
Not applicableStudy completedNCT00246402
What this trial is testing

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Who this might be right for
Insulin ResistanceCardiovascular DiseasesHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI) 30
Not applicableStudy completedNCT03075332
What this trial is testing

Detraining in People Living With HIV/AIDS

Who this might be right for
Lipodystrophy Syndrome, HIVSarcopenia
Universidade Federal do Rio Grande do Norte 2
Post-approval studies (Phase 4)Ended earlyNCT00126308
What this trial is testing

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Who this might be right for
HIV-Associated LipodystrophyHIV Infections
Kirby Institute 100
Large-scale testing (Phase 3)Ended earlyNCT00148850
What this trial is testing

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Who this might be right for
HIV-Associated Lipodystrophy SyndromeHIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Large-scale testing (Phase 3)Study completedNCT00082628
What this trial is testing

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

Who this might be right for
HIV InfectionsLipodystrophy
EMD Serono 326
Not applicableStudy completedNCT00524992
What this trial is testing

Evaluation of Albuminuria HIV-Infected Patients

Who this might be right for
HIV-Associated Focal Segmental GlomerulosclerosisHIV-Associated Collapsing GlomerulopathyProteinuria+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 252
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Next Page